Prioritizing vaccine introduction to China's National Immunization Program: a multi-criteria decision analysis.

ABSTRACT:

Background

To prioritize the introducing of new vaccines into China's National Immunization Program (NIP) among 10 candidate vaccines across four classes.

Methods

We developed a vaccine value framework using Multi-Criteria Decision Analysis (MCDA) to simulate the introduction of new vaccines into NIP, covering 21 criteria encompassing six dimensions: safety, effectiveness, economy, innovation, accessibility, and appropriateness. Two decision scenarios were considered: Scenario One prioritized the four classes of vaccines, while Scenario Two identified specific vaccines within each class.

Results

In the vaccine value framework, safety received the highest weight, while innovation received the lowest. The Human Papillomavirus (HPV) vaccine was identified as a top priori

SUBMITTER: Guo J 

PROVIDER: S-EPMC11658352 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature